Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
Nicolas Alejandro Fraunhoffer,
Analía Meilerman Abuelafia,
Brice Chanez,
Martin Bigonnet,
Odile Gayet,
Julie Roques,
Eduardo Chuluyan,
Nelson Dusetti,
Juan Iovanna
Affiliations
Nicolas Alejandro Fraunhoffer
Cancer Research Center of Marseille, Inserm, Paoli‐Calmettes Institut, Aix‐Marseille University, Scientific and Technological Park of Luminy Marseille 13288 France
Analía Meilerman Abuelafia
Cancer Research Center of Marseille, Inserm, Paoli‐Calmettes Institut, Aix‐Marseille University, Scientific and Technological Park of Luminy Marseille 13288 France
Brice Chanez
Cancer Research Center of Marseille, Inserm, Paoli‐Calmettes Institut, Aix‐Marseille University, Scientific and Technological Park of Luminy Marseille 13288 France
Martin Bigonnet
Cancer Research Center of Marseille, Inserm, Paoli‐Calmettes Institut, Aix‐Marseille University, Scientific and Technological Park of Luminy Marseille 13288 France
Odile Gayet
Cancer Research Center of Marseille, Inserm, Paoli‐Calmettes Institut, Aix‐Marseille University, Scientific and Technological Park of Luminy Marseille 13288 France
Julie Roques
Cancer Research Center of Marseille, Inserm, Paoli‐Calmettes Institut, Aix‐Marseille University, Scientific and Technological Park of Luminy Marseille 13288 France
Eduardo Chuluyan
Buenos Aires University, Center for Pharmacological and Botanical Studies, Faculty of Medicine, National Council for Scientific and Technical Research, Buenos Aires C1121ABG Argentina
Nelson Dusetti
Cancer Research Center of Marseille, Inserm, Paoli‐Calmettes Institut, Aix‐Marseille University, Scientific and Technological Park of Luminy Marseille 13288 France
Juan Iovanna
Cancer Research Center of Marseille, Inserm, Paoli‐Calmettes Institut, Aix‐Marseille University, Scientific and Technological Park of Luminy Marseille 13288 France
